TY - JOUR
T1 - Antiseizure medication withdrawal risk estimation and recommendations
T2 - a survey of American Academy of Neurology and EpiCARE members
AU - Terman, Samuel W
AU - van Griethuysen, Renate
AU - Rheaume, Carole E
AU - Slinger, Geertruida
AU - Haque, Anisa S
AU - Smith, Shawna N
AU - Kerr, Wesley T
AU - van Asch, Charlotte
AU - Otte, Willem M
AU - Ferreira-Atuesta, Carolina
AU - Galovic, Marian
AU - Burke, James F
AU - Braun, Kees Pj
N1 - Funding Information:
These funding sources had no role in the survey, other than American Academy of Neurology which funded staff to execute this survey. Dr Terman is supported by the American Epilepsy Society Susan S Spencer Clinical Research Training Scholarship and the Michigan Institute for Clinical and Health Research J Award UL1TR002240. Dr Terman was a member of the Junior Investigator Intensive Program of the US Deprescribing Research Network, which is funded by the National Institute on Aging (R24AG064025). Ms van Griethuysen is supported by the friends UMC Utrecht/MING Fund. Ms Rheaume is employed by the American Academy of Neurology. Dr Slinger is supported by the friends UMC Utrecht/MING Fund. Ms Haque reports no relevant funding. Dr Smith reports no relevant funding. Dr Kerr is supported by National Institutes of Health R25NS065723, U24NS107158, and the American Epilepsy Society. Dr van Asch reports no relevant funding. Dr Otte is supported by the friends UMC Utrecht/MING Fund. Dr Ferreira‐Atuesta reports no relevant funding. Dr Galovic reports no relevant funding. Dr Burke is supported by National Institutes of Health National Institute of Aging R01 AG068410. Dr Braun is supported by the friends UMC Utrecht/MING Fund.
Publisher Copyright:
© 2023 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
PY - 2023/6
Y1 - 2023/6
N2 - Objective: Choosing candidates for antiseizure medication (ASM) withdrawal in well-controlled epilepsy is challenging. We evaluated (a) the correlation between neurologists' seizure risk estimation (“clinician predictions”) vs calculated predictions, (b) how viewing calculated predictions influenced recommendations, and (c) barriers to using risk calculation. Methods: We asked US and European neurologists to predict 2-year seizure risk after ASM withdrawal for hypothetical vignettes. We compared ASM withdrawal recommendations before vs after viewing calculated predictions, using generalized linear models. Results: Three-hundred and forty-six neurologists responded. There was moderate correlation between clinician and calculated predictions (Spearman coefficient 0.42). Clinician predictions varied widely, for example, predictions ranged 5%-100% for a 2-year seizure-free adult without epileptiform abnormalities. Mean clinician predictions exceeded calculated predictions for vignettes with epileptiform abnormalities (eg, childhood absence epilepsy: clinician 65%, 95% confidence interval [CI] 57%-74%; calculated 46%) and surgical vignettes (eg, focal cortical dysplasia 6-month seizure-free mean clinician 56%, 95% CI 52%-60%; calculated 28%). Clinicians overestimated the influence of epileptiform EEG findings on withdrawal risk (26%, 95% CI 24%-28%) compared with calculators (14%, 95% 13%-14%). Viewing calculated predictions slightly reduced willingness to withdraw (−0.8/10 change, 95% CI −1.0 to −0.7), particularly for vignettes without epileptiform abnormalities. The greatest barrier to calculator use was doubting its accuracy (44%). Significance: Clinicians overestimated the influence of abnormal EEGs particularly for low-risk patients and overestimated risk and the influence of seizure-free duration for surgical patients, compared with calculators. These data may question widespread ordering of EEGs or time-based seizure-free thresholds for surgical patients. Viewing calculated predictions reduced willingness to withdraw particularly without epileptiform abnormalities.
AB - Objective: Choosing candidates for antiseizure medication (ASM) withdrawal in well-controlled epilepsy is challenging. We evaluated (a) the correlation between neurologists' seizure risk estimation (“clinician predictions”) vs calculated predictions, (b) how viewing calculated predictions influenced recommendations, and (c) barriers to using risk calculation. Methods: We asked US and European neurologists to predict 2-year seizure risk after ASM withdrawal for hypothetical vignettes. We compared ASM withdrawal recommendations before vs after viewing calculated predictions, using generalized linear models. Results: Three-hundred and forty-six neurologists responded. There was moderate correlation between clinician and calculated predictions (Spearman coefficient 0.42). Clinician predictions varied widely, for example, predictions ranged 5%-100% for a 2-year seizure-free adult without epileptiform abnormalities. Mean clinician predictions exceeded calculated predictions for vignettes with epileptiform abnormalities (eg, childhood absence epilepsy: clinician 65%, 95% confidence interval [CI] 57%-74%; calculated 46%) and surgical vignettes (eg, focal cortical dysplasia 6-month seizure-free mean clinician 56%, 95% CI 52%-60%; calculated 28%). Clinicians overestimated the influence of epileptiform EEG findings on withdrawal risk (26%, 95% CI 24%-28%) compared with calculators (14%, 95% 13%-14%). Viewing calculated predictions slightly reduced willingness to withdraw (−0.8/10 change, 95% CI −1.0 to −0.7), particularly for vignettes without epileptiform abnormalities. The greatest barrier to calculator use was doubting its accuracy (44%). Significance: Clinicians overestimated the influence of abnormal EEGs particularly for low-risk patients and overestimated risk and the influence of seizure-free duration for surgical patients, compared with calculators. These data may question widespread ordering of EEGs or time-based seizure-free thresholds for surgical patients. Viewing calculated predictions reduced willingness to withdraw particularly without epileptiform abnormalities.
KW - antiseizure medications
KW - discontinuation
KW - epilepsy
KW - survey
UR - http://www.scopus.com/inward/record.url?scp=85148287020&partnerID=8YFLogxK
U2 - 10.1002/epi4.12696
DO - 10.1002/epi4.12696
M3 - Article
C2 - 36721311
SN - 2470-9239
VL - 8
SP - 386
EP - 398
JO - Epilepsia Open
JF - Epilepsia Open
IS - 2
ER -